| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K90370028 | CTRPv2 | pan-cancer | AAC | -0.07 | 0.2 |
| mRNA | NVP-231 | CTRPv2 | pan-cancer | AAC | -0.042 | 0.2 |
| mRNA | masitinib | GDSC1000 | pan-cancer | AAC | 0.041 | 0.2 |
| mRNA | BRD-K45681478 | CTRPv2 | pan-cancer | AAC | 0.047 | 0.2 |
| mRNA | tacedinaline | CTRPv2 | pan-cancer | AAC | -0.049 | 0.2 |
| mRNA | Erlotinib | UHNBreast | pan-cancer | AAC | 0.35 | 0.2 |
| mRNA | VX-680 | CTRPv2 | pan-cancer | AAC | -0.13 | 0.2 |
| mRNA | isonicotinohydroxamic acid | CTRPv2 | pan-cancer | AAC | -0.059 | 0.2 |
| mRNA | NVP-ADW742 | CTRPv2 | pan-cancer | AAC | -0.044 | 0.2 |
| mRNA | BRD-K29086754 | CTRPv2 | pan-cancer | AAC | 0.093 | 0.2 |